Rifampin stability in 7H9 broth and Löwenstein-Jensen medium

Journal of Clinical Microbiology

Volumn 49, Issue 3, 2011, Pages 784-789

  Yu, Xia ^a   Jiang, Guanglu ^a   Li, Huiwen ^a   Zhao, Yanlin ^a   Zhang, Hongtao ^a   Zhao, Liping ^a   Ma, Yu ^a   Coulter, Christopher ^b   Huang, Hairong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

7H9 BROTH; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG DECOMPOSITION; DRUG DEGRADATION; DRUG STABILITY; DRUG STORAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOWENSTEIN-JENSEN MEDIUM; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; STORAGE TEMPERATURE; TEMPERATURE SENSITIVITY; VALIDATION PROCESS;

ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CULTURE MEDIA; DRUG STABILITY; HUMANS; RIFAMPIN; TEMPERATURE;

MYCOBACTERIUM TUBERCULOSIS;

EID: 79952327501     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01951-10     Document Type: Article

References (14)

1. Chan, E. D., and M. D. Iseman. 2008. Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Curr. Opin. Infect. Dis. 21:587-595.
2. Cheneviera, P., L. Massiasa, D. Gueylarda, and R. Farinotti. 1998. Determination of ethambutol in plasma by high-performance liquid chromatography after pre-column derivatization. J. Chromatogr. B Biomed. Sci. Appl. 708:310-315.
3. Espinal, M. A., et al. 2000. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcome in 6 countries. JAMA 283:2537-2545. (Pubitemid 30324196)
4. Franzblau, S. G., et al. 1998. Rapid, low-technology MIC determination with clinical M. tuberculosis isolates by using the Microplate Alamar Blue assay. J. Clin. Microbiol. 36:362-366.
5. Griffith, M. E., and H. L. Bodily. 1992. Stability of antimycobacterial drugs in susceptibility testing. Antimicrob. Agents Chemother. 36:2398-2402.
6. Hartkoorn, R. C., et al. 2007. A rapid and sensitive HPLC-MS method for the detection of plasma and cellular rifampicin. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 857:76-82.
7. Homorodean, D., C. Diaconescu, S. E. Henegariu, S. D. Creçtu, and C. D. Zamora. 1997. The comparative results of the antibiograms for Mycobacterium tuberculosis performed in 2 different laboratories. Pneumoftiziologia 46:21-22.
8. Mandich, M. B., S. K. Ritchie, and M. Mullett. 1996. Transition times to oral feeding in premature infants with and without apnea. J. Obstet. Gynecol. Neonatal Nurs. 25:771-776.
9. Migliori, G. B., M. Espinal, I. D. Danilova, V. V. Punga, M. Grzemska, and M. C. Raviglione. 2002. Frequency of recurrence among MDR-TB cases 'successfully' treated with standardised short-course chemotherapy. Int. J. Tuberc. Lung Dis. 6:858-864. (Pubitemid 35190698)
10. Mukherjee, J. S., et al. 2004. Programmes and principles for management of multidrug-resistant tuberculosis. Lancet 363:474-481. (Pubitemid 38210067)
11. Quenelle, D., et al. 2004. Sustained release characteristics of rifampin-loaded microsphere formulations in nonhuman primates. Drug Deliv. 11:239-246. (Pubitemid 39096042)
12. Ramaswamy, S., and J. M. Musser. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79:3-29.
13. Sharma, S. K., and A. Mohan. 2006. Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. Chest 130:261-272. (Pubitemid 44116869)
14. World Health Organization. 1998. Laboratory services in tuberculosis control. Part III: culture. World Health Organization, Geneva, Switzerland.